Business Context and Reporting Period
Company: On Assignment, Inc. (Note: Input metadata referenced "Everforth Inc," but the filing text identifies the registrant as On Assignment, Inc.)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2004
Business Overview: A leading provider of skilled temporary professionals to clients in the science and healthcare industries. The company operates two segments: Healthcare Staffing (Nurse Travel, Medical Financial, and Allied) and Lab Support (scientific staffing for biotechnology, pharmaceutical, and other industries).
Key Financial Metrics
| Metric | Q1 2004 | Q1 2003 |
|---|---|---|
| Revenues | $46,426,000 | $57,825,000 |
| Gross Profit | $11,813,000 | $15,480,000 |
| Gross Margin | 25.4% | 26.8% |
| Operating Loss | $(2,536,000) | $(863,000) |
| Net Loss | $(1,503,000) | $(452,000) |
| Loss Per Share (Basic/Diluted) | $(0.06) | $(0.02) |
| Cash and Cash Equivalents | $34,608,000 | $29,488,000 |
| Working Capital | $52,351,000 | N/A |
| Net Cash from Operating Activities | $853,000 | $(2,038,000) |
| Total Debt | $0 | $0 |
Material Changes vs. Prior Period
- Revenue Decline: Total revenues decreased 19.7% to $46.4 million. The Healthcare Staffing segment dropped 19.5% (driven by a 31.4% decrease in temporary professionals on assignment), while the Lab Support segment fell 20.0% due to reduced R&D spending in the biotechnology sector.
- Widening Operating Loss: Operating loss increased from $863,000 to $2.5 million. While SG&A expenses decreased 12.2% due to prior cost-cutting measures, the decline in revenue caused SG&A as a percentage of revenue to rise from 28.3% to 30.9%.
- Cost of Services: Decreased 18.3% to $34.6 million, tracking with the reduction in staff on assignment. However, the cost of services as a percentage of revenue increased to 74.6% due to higher workers' compensation expenses and payroll taxes.
- Cash Flow Improvement: The company generated positive operating cash flow of $853,000, a significant improvement over the $2.0 million outflow in the prior year, driven by a reduction in accounts receivable and prepaid expenses.
Guidance, Outlook, and Risks
- Management Outlook: Management does not expect to generate net income for the full year 2004 due to the timing of resource investments associated with a revitalization plan and the current performance of the Medical Financial and Allied lines.
- Strategic Focus: The company is implementing a revitalization plan to grow revenues through organic growth, hiring experienced staffing veterans, and expanding the Lab Support segment internationally (UK, Netherlands, Belgium).
- Capital Expenditures: The company expects to incur an additional $4.0 million to $4.4 million in capital expenditures over the next nine months, primarily for the PeopleSoft enterprise system and leasehold improvements.
- Risks and Contingencies:
- Goodwill Impairment: While no impairment was recorded in Q1 2004, the company previously recorded a $79.9 million impairment charge in Q2 2003. Management continues to evaluate goodwill for impairment.
- Liquidity: Liquidity relies on cash flows from operations. A decrease in demand for staffing services could adversely impact liquidity.
- Seasonality: Results are subject to seasonal fluctuations, with reduced demand typically occurring during the holiday season and summer months.
Investor Verification Checklist
- Revenue Recovery: Verify if the "revitalization plan" is successfully reversing the 20% revenue decline in both Healthcare and Lab Support segments.
- Medical Financial Segment: Monitor the Medical Financial and Allied line, which saw a 46.4% revenue drop and is cited as a primary reason for the lack of 2004 profitability.
- Capital Expenditure Timing: Confirm the timing and ROI of the $4.4 million planned investment in PeopleSoft and infrastructure.
- Workers' Compensation Costs: Track the trend of workers' compensation expenses, which contributed to the widening gross margin compression.
- Goodwill Valuation: Review future filings for any new triggers requiring goodwill impairment testing given the remaining $43.5 million balance.